Cargando…
Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach
INTRODUCTION: The increasing burden of dengue fever (DF) in the Americas, and the current epidemic in previously unaffected countries, generate major costs for national healthcare systems. There is a need to quantify the average cost per DF case. In Mexico, few data are available on costs, despite D...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976855/ https://www.ncbi.nlm.nih.gov/pubmed/27501146 http://dx.doi.org/10.1371/journal.pntd.0004897 |
_version_ | 1782446926881357824 |
---|---|
author | Zubieta-Zavala, Adriana Salinas-Escudero, Guillermo Ramírez-Chávez, Adrian García-Valladares, Luis López-Cervantes, Malaquias López Yescas, Juan Guillermo Durán-Arenas, Luis |
author_facet | Zubieta-Zavala, Adriana Salinas-Escudero, Guillermo Ramírez-Chávez, Adrian García-Valladares, Luis López-Cervantes, Malaquias López Yescas, Juan Guillermo Durán-Arenas, Luis |
author_sort | Zubieta-Zavala, Adriana |
collection | PubMed |
description | INTRODUCTION: The increasing burden of dengue fever (DF) in the Americas, and the current epidemic in previously unaffected countries, generate major costs for national healthcare systems. There is a need to quantify the average cost per DF case. In Mexico, few data are available on costs, despite DF being endemic in some areas. Extrapolations from studies in other countries may prove unreliable and are complicated by the two main Mexican healthcare systems (the Secretariat of Health [SS] and the Mexican Social Security Institute [IMSS]). The present study aimed to generate specific average DF cost-per-case data for Mexico using a micro-costing approach. METHODS: Expected medical costs associated with an ideal management protocol for DF (denoted ´ideal costs´) were compared with the medical costs of current treatment practice (denoted ´real costs´) in 2012. Real cost data were derived from chart review of DF cases and interviews with patients and key personnel from 64 selected hospitals and ambulatory care units in 16 states for IMSS and SS. In both institutions, ideal and real costs were estimated using the program, actions, activities, tasks, inputs (PAATI) approach, a micro-costing technique developed by us. RESULTS: Clinical pathways were obtained for 1,168 patients following review of 1,293 charts. Ideal and real costs for SS patients were US$165.72 and US$32.60, respectively, in the outpatient setting, and US$587.77 and US$490.93, respectively, in the hospital setting. For IMSS patients, ideal and real costs were US$337.50 and US$92.03, respectively, in the outpatient setting, and US$2,042.54 and US$1,644.69 in the hospital setting. CONCLUSIONS: The markedly higher ideal versus real costs may indicate deficiencies in the actual care of patients with DF. It may be necessary to derive better estimates with micro-costing techniques and compare the ideal protocol with current practice when calculating these costs, as patients do not always receive optimal care. |
format | Online Article Text |
id | pubmed-4976855 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-49768552016-08-25 Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach Zubieta-Zavala, Adriana Salinas-Escudero, Guillermo Ramírez-Chávez, Adrian García-Valladares, Luis López-Cervantes, Malaquias López Yescas, Juan Guillermo Durán-Arenas, Luis PLoS Negl Trop Dis Research Article INTRODUCTION: The increasing burden of dengue fever (DF) in the Americas, and the current epidemic in previously unaffected countries, generate major costs for national healthcare systems. There is a need to quantify the average cost per DF case. In Mexico, few data are available on costs, despite DF being endemic in some areas. Extrapolations from studies in other countries may prove unreliable and are complicated by the two main Mexican healthcare systems (the Secretariat of Health [SS] and the Mexican Social Security Institute [IMSS]). The present study aimed to generate specific average DF cost-per-case data for Mexico using a micro-costing approach. METHODS: Expected medical costs associated with an ideal management protocol for DF (denoted ´ideal costs´) were compared with the medical costs of current treatment practice (denoted ´real costs´) in 2012. Real cost data were derived from chart review of DF cases and interviews with patients and key personnel from 64 selected hospitals and ambulatory care units in 16 states for IMSS and SS. In both institutions, ideal and real costs were estimated using the program, actions, activities, tasks, inputs (PAATI) approach, a micro-costing technique developed by us. RESULTS: Clinical pathways were obtained for 1,168 patients following review of 1,293 charts. Ideal and real costs for SS patients were US$165.72 and US$32.60, respectively, in the outpatient setting, and US$587.77 and US$490.93, respectively, in the hospital setting. For IMSS patients, ideal and real costs were US$337.50 and US$92.03, respectively, in the outpatient setting, and US$2,042.54 and US$1,644.69 in the hospital setting. CONCLUSIONS: The markedly higher ideal versus real costs may indicate deficiencies in the actual care of patients with DF. It may be necessary to derive better estimates with micro-costing techniques and compare the ideal protocol with current practice when calculating these costs, as patients do not always receive optimal care. Public Library of Science 2016-08-08 /pmc/articles/PMC4976855/ /pubmed/27501146 http://dx.doi.org/10.1371/journal.pntd.0004897 Text en © 2016 Zubieta-Zavala et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Zubieta-Zavala, Adriana Salinas-Escudero, Guillermo Ramírez-Chávez, Adrian García-Valladares, Luis López-Cervantes, Malaquias López Yescas, Juan Guillermo Durán-Arenas, Luis Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach |
title | Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach |
title_full | Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach |
title_fullStr | Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach |
title_full_unstemmed | Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach |
title_short | Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach |
title_sort | calculation of the average cost per case of dengue fever in mexico using a micro-costing approach |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976855/ https://www.ncbi.nlm.nih.gov/pubmed/27501146 http://dx.doi.org/10.1371/journal.pntd.0004897 |
work_keys_str_mv | AT zubietazavalaadriana calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach AT salinasescuderoguillermo calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach AT ramirezchavezadrian calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach AT garciavalladaresluis calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach AT lopezcervantesmalaquias calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach AT lopezyescasjuanguillermo calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach AT duranarenasluis calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach |